Health
NVAX Stock – Novavax vaccine effective vs COVID-19 variants – expert – Fintech Zoom
Stock analysis for Novavax Inc (NVAX:NASDAQ GS) including stock price, stock chart, company news, key statistics and fundamentals.
NVAX Stock – Novavax vaccine effective vs COVID-19 variants expert
Ghio Ong (The Philippine Star) – March 11, 2021 – 12:00am
MANILA, Philippines Theres a good chance that the COVID-19 vaccine developed by American drug firm Novavax could provide immunity against the other variants of the disease, a health expert revealed yesterday.
Speaking at the online Kapihan sa Manila Bay media forum, Dr. Luningning Villa, medical director of Faberco Life Sciences Inc., said Novavaxs Covovax has seen high efficacy…
-
Noosa News23 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Noosa News23 hours agoBali traveller sparks urgent measles alert across Queensland
-
Business23 hours agoThe best ASX ETFs for compounding wealth until 2040
-
Noosa News21 hours agoMeasles alert issued south of Brisbane after traveller tests positive